Articles tagged with ‘SUMM

Hold Summit Corporation

In: Tips

4 Jul 2011

Summit Corporation – Announces a Novel Alzheimer Drug Candidate – Data to be Presented at Major Global Alzheimer Conference; Target Price 7.8p Summit Corporation, the UK based drug discovery company using its innovative Seglin™ drug discovery platform to identify candidates for areas of high unmet clinical need ,has announced positive news, this time from its […]

Summit Corporation – Positive Data for Drug Candidate SMT C1100, No Change to Forecasts – Buy at 4.375p with 5.7p target price Summit Corporation, the UK based drug discovery company using its innovative Seglin™ drug discovery platform, has this morning announced positive non-clinical efficacy data for its Duchenne Muscular Dystrophy (‘DMD’) oral candidate SMT C1100. […]



Categories